glucose, (beta-d)-isomer has been researched along with Deficiency, Glucosephosphatase in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adrian, K; Al-Thihli, K; Ballhausen, D; Bidiuk, J; Bordugo, A; Boyer, M; Bratkovic, D; Brunner-Krainz, M; Burlina, A; Chakrapani, A; Corpeleijn, W; Cozens, A; Dawson, C; Derks, TGJ; Dhamko, H; Eiroa, H; Finezilber, Y; Fraile, PQ; Fung, LH; Garcia-Jiménez, MC; Gasperini, S; Grünert, SC; Haas, D; Häberle, J; Halligan, R; Hörbe-Blindt, A; Horka, LM; Huemer, M; Kecman, B; Kilavuz, S; Kriván, G; Lindner, M; Lüsebrink, N; Maier, EM; Maiorana, A; Makrilakis, K; McCandless, SE; Mei-Kwun Kwok, A; Milosevic, MD; Mitchell, JJ; Mizumoto, H; Moura de Souza, CF; Mundy, H; Ochoa, C; Pierce, K; Regier, D; Rossi, A; Santer, R; Schrier Vergano, SA; Schuman, HC; Sobieraj, P; Spenger, J; Spiegel, R; Stepien, KM; Tal, G; Tanšek, MZ; Tchan, M; Thyagu, S; Torkar, AD; Uçar, SK; Vucko, E; Weinhold, N; Wortmann, SB; Zsidegh, P | 1 |
| Boulanger, C; Chevalier, N; Diederich, J; Ferster, A; Mounkoro, P; Stephenne, X; Van Schaftingen, E; Veiga-da-Cunha, M | 1 |
| Dionisi-Vici, C; Maiorana, A; Tagliaferri, F | 1 |
| Chevalier, N; Derks, TGJ; Gaughan, S; Knight, V; Koller, A; Lagler, FB; Mayr, JA; Oussoren, E; Van Hove, JLK; Van Schaftingen, E; van Spronsen, FJ; Veiga-da-Cunha, M; Wortmann, SB | 1 |
| Derks, TGJ; Elling, R; Grünert, SC; Hannibal, L; Maag, B; Rosenbaum-Fabian, S; Schumann, A; Spiekerkoetter, U; Wortmann, SB | 1 |
| D'Armiento, M; Derks, TGJ; Fecarotta, S; Martinelli, M; Miele, E; Mollica, C; Mozzillo, E; Parenti, G; Rossi, A; Staiano, A; Strisciuglio, P; Veiga-da-Cunha, M | 1 |
| Arai, A; Mikami, M; Mizumoto, H | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Deficiency, Glucosephosphatase
| Article | Year |
|---|---|
Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders.
Topics: Animals; Diabetes Mellitus, Type 2; Glucose; Glucosides; Glycogen; Glycogen Storage Disease Type I; Hypoglycemia; Rats | 2023 |
6 other study(ies) available for glucose, (beta-d)-isomer and Deficiency, Glucosephosphatase
| Article | Year |
|---|---|
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.
Topics: Adolescent; Adult; Benzhydryl Compounds; Child; Child, Preschool; Glucosides; Glycogen Storage Disease Type I; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Neutropenia; Retrospective Studies; Surveys and Questionnaires; Young Adult | 2022 |
Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.
Topics: Animals; Antiporters; Benzhydryl Compounds; Glucose-6-Phosphatase; Glucosides; Glycogen Storage Disease Type I; Humans; Mice; Monosaccharide Transport Proteins; Mutation; Neutropenia; Phosphoric Monoester Hydrolases; Sodium-Glucose Transport Proteins | 2022 |
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Topics: Benzhydryl Compounds; Blood Glucose; Chemotaxis, Leukocyte; Child, Preschool; Drug Repositioning; Drug Resistance; Female; Glucosides; Glycogen Storage Disease Type I; Granulocyte Colony-Stimulating Factor; Granulocytes; Hexosephosphates; Humans; Infant, Newborn; Lysosomal-Associated Membrane Protein 2; Male; Neutropenia; Neutrophils; Off-Label Use; Respiratory Burst; Sodium-Glucose Transporter 2 Inhibitors; Young Adult | 2020 |
Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib.
Topics: Adult; Antiporters; Benzhydryl Compounds; Female; Glucosides; Glycogen Storage Disease Type I; Humans; Inflammatory Bowel Diseases; Monosaccharide Transport Proteins; Respiratory Burst; Wound Healing | 2020 |
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report.
Topics: Adolescent; Benzhydryl Compounds; Crohn Disease; Enterocolitis; Glucosides; Glycogen Storage Disease Type I; Granulocyte Colony-Stimulating Factor; Humans; Male; Remission Induction; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Empagliflozin ameliorated neutropenia in a girl with glycogen storage disease Ib.
Topics: Benzhydryl Compounds; Female; Glucosides; Glycogen Storage Disease Type I; Humans; Neutropenia | 2021 |